Advances in chronic spontaneous urticaria: Expert insight on translating progress to practice for improved symptom control and quality of life
Sunday, March 27
In this PeerView live “Master Class and Practicum” event, expert faculty will address current diagnostic/treatment strategies for chronic spontaneous urticaria (CSU) and the latest clinical data regarding emerging therapies, as well as the mechanisms of action, efficacy, and safety of these novel agents. They will provide practical guidance on how to effectively integrate the latest evidence and expert recommendations into real-world clinical scenarios, providing the necessary tools to effectively navigate the rapidly changing landscape for CSU.
Supported by: An educational grant from Sanofi Genzyme and Regeneron Pharmaceuticals
When: Sunday, March 27 | 6:30 p.m. Registration | 7:00 p.m. Program
Where: Atlantic ABC | Renaissance Boston Waterfront Hotel